1. Home
  2. INVZ vs TNXP Comparison

INVZ vs TNXP Comparison

Compare INVZ & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVZ
  • TNXP
  • Stock Information
  • Founded
  • INVZ 2016
  • TNXP 2007
  • Country
  • INVZ Israel
  • TNXP United States
  • Employees
  • INVZ N/A
  • TNXP N/A
  • Industry
  • INVZ Auto Parts:O.E.M.
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVZ Consumer Discretionary
  • TNXP Health Care
  • Exchange
  • INVZ Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • INVZ 369.4M
  • TNXP 335.6M
  • IPO Year
  • INVZ N/A
  • TNXP N/A
  • Fundamental
  • Price
  • INVZ $2.36
  • TNXP $24.22
  • Analyst Decision
  • INVZ Strong Buy
  • TNXP Buy
  • Analyst Count
  • INVZ 4
  • TNXP 1
  • Target Price
  • INVZ $3.27
  • TNXP $70.00
  • AVG Volume (30 Days)
  • INVZ 9.6M
  • TNXP 1.1M
  • Earning Date
  • INVZ 11-12-2025
  • TNXP 11-11-2025
  • Dividend Yield
  • INVZ N/A
  • TNXP N/A
  • EPS Growth
  • INVZ N/A
  • TNXP N/A
  • EPS
  • INVZ N/A
  • TNXP N/A
  • Revenue
  • INVZ $37,684,000.00
  • TNXP $9,831,000.00
  • Revenue This Year
  • INVZ $153.22
  • TNXP $14.79
  • Revenue Next Year
  • INVZ $91.44
  • TNXP $933.49
  • P/E Ratio
  • INVZ N/A
  • TNXP N/A
  • Revenue Growth
  • INVZ 17.32
  • TNXP N/A
  • 52 Week Low
  • INVZ $0.45
  • TNXP $6.76
  • 52 Week High
  • INVZ $3.14
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • INVZ 69.27
  • TNXP 37.95
  • Support Level
  • INVZ $1.66
  • TNXP $23.56
  • Resistance Level
  • INVZ $2.21
  • TNXP $25.40
  • Average True Range (ATR)
  • INVZ 0.17
  • TNXP 1.59
  • MACD
  • INVZ 0.05
  • TNXP 0.37
  • Stochastic Oscillator
  • INVZ 85.37
  • TNXP 11.72

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: